Global Injectable Drug Delivery Market

Focus on Devices, Competitive Landscape and Country - Analysis and Forecast (2018-2025)

Published Year: 2018
SKU: BHM0582SA

4599

Online Access for 1-3 Users. Permission to Print.


In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Table of Contents

Download this TOC  

Request a Sample

1 Market Overview

1.1.    Introduction
1.2.    History of Injectable Drug Delivery Systems
1.3.    Onset of Prefilled-Syringes
1.4.    Introduction of Needle-Free Technology
1.5.    Advantages of Prefilled Syringes Over Traditional Vial & Syringe System
1.6.    Prefilled Syringes: Manufacturing and Packaging Challenges
1.7.    Components of Prefilled Syringes
1.8.    Benefits of Prefilled Syringes to the Pharmaceutical Companies
1.9.    Rising Prevalence of Diabetes
1.10.    Diabetes Prevalence in Different Countries (2017 Estimates)
1.11.    Rising Prevalence of Diabetes and Use of Insulin Delivery Devices

2 Market Dynamics

2.1.    Overview
2.2.    Impact Analysis
2.3.    Market Drivers
2.4.    Market Restraints
2.5.    Market Opportunities

3 Competitive Landscape

3.1.    Key Developments & Strategies 
3.2.    Recent Market Development Strategy Snapshot Analysis
3.3.    Porter’s Five Forces Analysis
3.3.1.    Bargaining Power of Suppliers
3.3.2    Bargaining Power of Buyers
3.3.3.    Threat of New Entrant
3.3.4.    Threat of Substitute
3.3.5.    Intensity of Competitive Rivalry 
3.4.    Market Share Analysis
3.4.1.    Market Share Analysis, Pen and Auto Injectors
3.4.2.    Market Share Analysis, Prefilled
3.4.3.    Market Share Analysis, Needle Free Injectors
3.5.    Assumptions & Limitations for Analysis & Forecast of the Global Injectable Drug Delivery Market

4 Industry Insights

4.1.    Patent Landscape
4.2.    Legal Requirements and Regulations
4.3.    Consortiums, Associations and Regulatory Bodies

5 Global Injectable Drug Delivery Market, By Device Type

5.1.    Introduction
5.2.    Needle Free Injectors (Gas-based, Spring-Based and Others)
5.2.1.    Global Needle Free Injector Market, By Region
5.3.    Auto-Injectors (Reusable & Disposable)
5.3.1    Global Auto-Injectors Market, By Region
5.4.    Pen Injectors (Reusable & Disposable)
5.4.1.    Pen Injectors for Insulin
5.4.2.    Global Pen Injectors Market, By Region
5.5.    Prefilled Syringes
5.5.1.    Global Prefilled Syringe Market, By Region
5.5.2.    Glass Prefilled Syringes
5.5.3.    Plastic Prefilled Syringes
5.5.4.    Single Chamber Prefilled Syringes
5.5.4.1.    Advantages of Hyaluronic Method of Single Chamber Prefilled Syringes Filling
5.5.5.    Dual Chamber Prefilled Syringes
5.5.5.1    Some of the Marketed Dual Chambered Prefilled Syringes
5.5.6.    Conventional Prefilled Syringe
5.5.7.    Some of the lyophilized drugs which are used in prefilled syringe format 
5.5.8.    Safety Prefilled Syringes
5.5.8.1.     Marketed Prefilled Safety Syringes
5.5.9.    Customized Prefilled Syringes
5.6.    Wearable Injectors (Qualitative)

6 Global Injectable Drug Delivery Market, By End User

6.1.    Different Types of End User
6.1.1.    Overview
6.1.2.    Home Based
6.1.3.    Hospital
6.1.4.    Ambulatory Care
6.1.5.    Clinics/Physician Offices
6.1.6    Others
6.2.    Global Prefilled Syringes Market, by End Users
6.3.    Global Needle Free Injector Market, by End Users
6.4.    Global Auto-Injectors Market, by End Users
6.5.    Global Pen Injection Market, by End Users

7 Global Injectable Drug Delivery Market, By Route Of Administration

7.1.    Overview
7.2.    Different Route of Administration (Intravenous, Subcutaneous, intramuscular and Others)
7.3.    Global Injectable Drug Delivery Market, By Route of Administration

8 Global Injectable Drug Delivery Market, By Region

8.1.    Geographical Scenario
8.2.    North America
8.2.1    The U.S.
8.2.2.    Canada
8.3.    Europe
8.3.1.    The U.K.
8.3.2.    Germany
8.3.3.    France
8.3.4.    Italy
8.3.5.    Spain
8.3.6.    Netherlands
8.3.7.    Switzerland
8.3.8.    Belgium
8.3.9.    Poland
8.3.10.    Austria
8.3.11.    Turkey
8.3.12.    Rest of Europe
8.4.    Asia Pacific (APAC)
8.4.1.    Japan
8.4.2.    China
8.4.3.    Australia
8.4.4.    South Korea
8.4.5.    India
8.4.6.    Malaysia
8.4.7.    Indonesia
8.4.8.    Rest of Asia Pacific
8.5.    Latin America
8.5.1.    Brazil
8.5.2.    Mexico
8.5.3.    Argentina
8.5.4.    Rest of Latin America
8.6.    Rest of the World (RoW)
8.6.1.    K.S.A
8.6.2.    Russia
8.6.3.    South Africa
8.6.4.    RoW

9 Company Profiles

9.1.    ALKERMES PUBLIC LIMITED COMPANY
9.1.1.    Overview
9.1.2.    Product Portfolio
9.1.3.    Financials
9.1.3.1.    Financial Summary
9.1.4.    SWOT Analysis
9.2.    Antares Pharma
9.2.1.    Overview
9.2.2.    Product Portfolio
9.2.3.    Financials
9.2.3.1.    Financial Summary
9.2.4.    SWOT Analysis
9.3.    Baxter International Inc.
9.3.1.    Overview
9.3.2.    Product Portfolio
9.3.3.    Financials
9.3.3.1.    Financial Summary
9.3.4.    SWOT Analysis
9.4.    Becton, Dickinson and Company 
9.4.1.    Overview
9.4.2.    Product Portfolio
9.4.3.    Financials
9.4.3.1.    Financial Summary
9.4.4.    SWOT Analysis
9.5.    Elcam Medical
9.5.1.    Overview
9.5.2.    Product Portfolio
9.5.3.    Corporate Summary
9.5.4.    SWOT Analysis
9.6.    Eli-Lilly and Company
9.6.1.    Overview
9.6.2.    Product Portfolio
9.6.3.    Financials
9.6.3.1.    Financial Summary
9.6.4.    SWOT Analysis
9.7.    Gerresheimer  AG
9.7.1.    Overview
9.7.2.    Product Portfolio
9.7.3.    Financials
9.7.3.1.    Financial Summary
9.7.4.    SWOT Analysis
9.8.    Injex Pharma GmbH
9.8.1.    Overview
9.8.2.    Product Portfolio
9.8.3.    Corporate Summary
9.8.4.    SWOT Analysis
9.9.    Novartis AG
9.9.1.    Overview
9.9.2.    Product Portfolio
9.9.3.    Financials
9.9.3.1.    Financial Summary
9.9.4.    SWOT Analysis
9.10.    NOVO NORDISK
9.10.1.    Overview
9.10.2.    Product Portfolio
9.10.3.    Financials
9.10.3.1.    Financial Summary
9.10.4.    SWOT Analysis
9.11.    Pfizer, Inc.
9.11.1.    Overview
9.11.2.    Product Portfolio
9.11.3.    Financials
9.11.3.1.    Financial Summary
9.11.4.    SWOT Analysis
9.12.    PharmaJet
9.12.1.    Overview
9.12.2.    Product Portfolio
9.12.3.    Corporate Summary
9.12.4.    SWOT Analysis
9.13.    SANOFI
9.13.1.    Overview
9.13.2.    Product Portfolio
9.13.3.    Financials
9.13.3.1.    Financial Summary
9.13.4.    SWOT Analysis
9.14.    Schott AG
9.14.1.    Overview
9.14.2.    Product Portfolio
9.14.3.    Financials
9.14.3.1.    Financial Summary
9.14.4.    SWOT Analysis
9.15.    Terumo Corporation
9.15.1.    Overview
9.15.2    Product Portfolio
9.15.3.    Financials
9.15.3.1.    Financial Summary
9.15.4.    SWOT Analysis
9.16.    Teva Pharmaceutical Industries Limited.
9.16.1.    Overview
9.16.2    Product Portfolio
9.16.3.    Financials
9.16.3.1.    Financial Summary
9.16.4.    SWOT Analysis
9.17.    Vetter Pharma-Fertigung GmbH & Co. KG
9.17.1.    Overview
9.17.2.    Product Portfolio
9.17.3.    Corporate Summary
9.17.4.    SWOT Analysis
9.18.    West Pharmaceutical Services, Inc.
9.18.1.    Overview
9.18.2    Product Portfolio
9.18.3.    Financials
9.18.3.1.    Financial Summary
9.18.4.    SWOT Analysis
9.19.    Ypsomed Holding AG
9.19.1.    Overview
9.19.2    Product Portfolio
9.19.3.    Financials
9.19.3.1.    Financial Summary
9.19.4.    SWOT Analysis

10 Report Scope & Methodology

10.1.    Scope of the Report
10.2.    Market Segmentation
10.3.    Research Methodology
10.3.1.    Primary Research
10.3.2    Secondary Research
10.3.3.    Key Data Points From Primary Sources 
10.3.4.    Data Triangulation
10.3.5.    Top-Down  Approach (Segmental Analysis)
10.3.6.    Bottom-Up Approach (Segmental Analysis)
10.4.    Assumptions and Limitations

List of Tables

1    Key Players in the Market
2    Impact of Market Drivers
3    Impact of Market Restraints
4    Components of Prefilled Syringes
5    Number of Diabetics Worldwide and As Per region In 2017 and 2045 (20-79 years
6    Comparative Prevalence of Diabetes in Different Countries (20-79 years)
7    Impact Analysis of Market Dynamics
8    Region-wise Percentage of Total Population Aged 65 years & Above: 2015 & 2030 
9    Factors Affecting the Bargaining Power of Buyer
10    Factors Affecting Threat of New Entrant
11    Factors Affecting the Threat of Substitute
12    Factors Affecting the Intensity of Competitive Rivalry
13    Patent Landscape
14    Consortiums, Associations and Regulatory Bodies
15    List of Some of the marketed products
16    Different types of Insulin Pen Injectors in Market
17    Regional Pen Injectors Market, By Value, 2016-2025 ($Million)
18    Regional Prefilled Syringe Market, By Value, 2016-2025 ($Million)
19    Regional Prefilled Syringe Market, By Volume, 2016-2025 (Million Units)
20    List of Some Dual Chamber Prefilled Syringes
21    List of Some Lyophilized Drugs which are used in Prefilled Syringe Format 
22    List of Some Recently Marketed Prefilled Safety Syringes Technologies 
23    Global Drug Delivery Market By Route of Admistration (2016-2025)
24    Percentages of Population Aged 60 Years and Above
25    ALKERMES PUBLIC LIMITED COMPANY: Overview 
26    Antares Pharma: Overview 
27    Baxter International Inc.: Overview 
28    Becton Dickinson and Company: Overview 
29    Elcam Medical: Overview
30    Eli-Lilly and Company: Overview
31    Gerresheimer  AG: Overview
32    Injex Pharma GmbH: Overview
33    Novartis AG: Overview
34    NOVO NORDISK: Overview
35    Pfizer, Inc.: Overview
36    PharmaJet: Overview
37    SANOFI: Overview
38    Schott AG: Overview
39    Terumo Corporation: Overview
40    Teva Pharmaceuticals Industries Limited.: Overview
41    Vetter Pharma-Fertigung GmbH & Co. KG: Overview
42    West Pharmaceutical Services, Inc.: Overview
43    Ypsomed Holding AG: Overview

List of Figures

1    Chronic Conditions: Key Statistics: 2016
2    The Global Injectable Drug Delivery Market ($Million)
3    Types of Injector Devices
4    Global Injectable Drug Delivery Market, by Device, 2016
5    Global Injectable Drug Delivery Market, by Devices, 2025
6    Global Injectable Drug Delivery Market, by End Users, 2016
7    Global Injectable Drug Delivery Market, by End Users, 2025
8    Global Injectable Drug Delivery Market, by Route of Administration, 2016
9    Global Injectable Drug Delivery Market, by Route of Administration, 2025
10    Global Injectable Drug Delivery Market, by Region, 2016
11    Global Injectable Drug Delivery Market, by Region, 2025
12    Various Types of Injectable Drug Delivery Devices
13    Limitations of Hypodermic Needles
14    Key Milestones in History of Syringes
15    The Key Advantages of Needle-Free Technology
16    Advancements in Injectable Drug Delivery Technology 
17    Advantages of Prefilled Syringes
18    Diabetes Statistics
19    Drivers Restraints and Opportunities
20    PER DAY COST SAVINGS VS. HOSPITAL
21    Share of the Key Strategies in the Global Injectable Drug Delivery Market
22    Porter’s Five Forces Analysis
23    Global Injectable Drug Delivery Market, 2016-2025 ($ Million)
24    Segmentation of Global Injectable Drug Delivery Market, By Device Type
25    Global Injectable Drug Delivery Market, By Device Type, 2016-2025 ($Million)
26    Global Needle Free Injector Market, 2016-2025 ($ Million)
27    Global Needle Free Injector Market, by type, 2016-2025 ($Million)
28    Advantages and Disadvantages of Needle Free Injectors
29    Types of Needle Free Injectors
30    Global Gas-Based Needle-Free Injectors Market, 2016-2025 ($Million)
31    Global Spring-Based Needle-Free Injectors Market, 2016-2025 ($Million)
32    Global Others Needle-Free Injectors Market, 2016-2025 ($Million)
33    Global Auto-Injector Market, 2016-2025 ($ Million)
34    Global Auto-injector Market, by Type, 2016-2025 ($Million)
35    Types of Pen Injectors
36    Global Pen Injector Market, 2016-2025 ($ Million)
37    Global Pen Injector Market, by type, 2016-2025 ($Million)
38    Global Prefilled Syringe Market, By Value, 2016-2025 ($Million)
39    Global Prefilled Syringe Market, By Volume, 2016-2025 (Million)
40    Global Glass Prefilled Syringes Market, By Value, 2016-2025 ($ Millions)
41    Global Glass Prefilled Syringe Market, By Volume, 2016-2025 (Million)
42    Global Plastic Prefilled Syringe Market, By Value, 2016-2025 ($Million)
43    Global Plastic Prefilled Syringe Market, By Volume, 2016-2025 (Million)
44    Global Single Chambered Prefilled Syringe Market, By Value, 2016-2025 ($Million)
45    Global Plastic Prefilled Syringe Market, By Volume, 2016-2025 (Million)
46    Global Dual Chambered Prefilled Syringe Market, By Value, 2016-2025 ($Million)
47    Global Dual Chambered Prefilled Syringe Market, By Volume, 2016-2025 (Million)
48    Global Customized Prefilled Syringes Market, by Value and Volume, 2016-2025 ($ Millions)
49    Global Customized Prefilled Syringe Market, By Volume, 2016-2025 (Million)
50    Types of End Users
51    Global Injectable Drug Delivery Market, by End Users (2016-2025)
52    Global Injectable Drug Delivery Market, by Home Based Treatment (2016-2025)
53    Global Injectable Drug Delivery Market, by Hospital (2016-2025)
54    Global Injectable Drug Delivery Market, by Ambulatory Care (2016-2025)
55    Global Injectable Drug Delivery Market, by Clinics/Physician Offices (2016-2025)
56    Global Injectable Drug Delivery Market, by Others (2016-2025)
57    Global Prefilled Syringes Market, by End Users (2016-2025)
58    Global Needle Free Market, by End Users 2016-2025)
59    Global Auto- Injectors Market, by End Users  (2016-2025)
60    Global Pen Injection Market, by End Users (2016-2025)
61    Different Routes of Administration
62    Global Drug Delivery Market By Route of Admistration (2016-2025)
63    Global Injectable Drug Delivery Market, By Region
64    Global Injectable Drug Delivery Market, by region, 2016-2025 ($Million)
65    North America Injectable Drug Delivery Market, 2016-2025 ($Million)
66    North America Injectable Drug Delivery Market, by Country, 2016-2025 ($Million)
67    The U.S. Injectable Drug Delivery Market, 2016-2025 ($million)
68    The U.S. Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
69    Canada Injectable Drug Delivery Market, 2016-2025 ($million)
70    Canada Injectable Drug Delivery Market, By Device 2016-2025 ($million)
71    Europe Injectable Drug Delivery Market, 2016-2025 ($Million)
72    The U.K. Injectable Drug Delivery Market, 2016-2025 ($million)
73    The U.K. Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
74    Germany Injectable Drug Delivery Market, 2016-2025 ($million)
75    Germany Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
76    France Injectable Drug Delivery Market, 2016-2025 ($million)
77    France Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
78    Italy Injectable Drug Delivery Market, 2016-2025 ($million)
79    Italy Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
80    Spain Injectable Drug Delivery Market, 2016-2025 ($million)
81    Spain Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
82    Netherlands Injectable Drug Delivery Market, 2016-2025 ($million)
83    Netherlands Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
84    Switzerland Injectable Drug Delivery Market, 2016-2025 ($million)
85    Switzerland Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
86    Belgium Injectable Drug Delivery Market, 2016-2025 ($million)
87    Belgium Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
88    Poland Injectable Drug Delivery Market, 2016-2025 ($million)
89    Poland Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
90    Austria Injectable Drug Delivery Market, 2016-2025 ($million)
91    Austria Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
92    Turkey Injectable Drug Delivery Market, 2016-2025 ($million)
93    Turkey Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
94    Rest of Europe Injectable Drug Delivery Market, 2016-2025 ($million)
95    Rest of Europe Injectable Drug Delivery Market, By Device, 2016-2025 ($million)
96    Asia Pacific Injectable Drug Delivery Market, 2016-2025 ($Million)
97    Japan Injectable Drug Delivery Market, by value, 2016-2025 ($million)
98    Japan Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
99    China Injectable Drug Delivery Market, by value, 2016-2025 ($million)
100    China Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
101    Australia Injectable Drug Delivery Market, by value, 2016-2025 ($million)
102    Australia Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
103    South Korea Injectable Drug Delivery Market, by value, 2016-2025 ($million)
104    South Korea Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
105    India Injectable Drug Delivery Market, by value, 2016-2025 ($million)
106    India Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
107    Malaysia Injectable Drug Delivery Market, by value, 2016-2025 ($million)
108    Malaysia Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
109    Indonesia Injectable Drug Delivery Market, by value, 2016-2025 ($million)
110    Indonesia Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
111    Rest of Asia Pacific Injectable Drug Delivery Market, by value, 2016-2025 ($million)
112    Rest of Asia Pacific Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
113    Prevalence of Diabetes in Brazil & Mexico
114    Latin America Injectable Drug Delivery Market, 2016-2025 ($Million)
115    Brazil Injectable Drug Delivery Market, by value, 2016-2025 ($million)
116    Brazil Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
117    Mexico Injectable Drug Delivery Market, by value, 2016-2025 ($million)
118    Mexico Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
119    Argentina Injectable Drug Delivery Market, by value, 2016-2025 ($million)
120    Argentina Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
121    Rest of Latin America Injectable Drug Delivery Market, by value, 2016-2025 ($million)
122    Rest of Latin America Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
123    RoW Injectable Drug Delivery Market, 2016-2025 ($Million)
124    K.S.A Injectable Drug Delivery Market, by value, 2016-2025 ($million)
125    K.S.A Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
126    Russia Injectable Drug Delivery Market, by value, 2016-2025 ($million)
127    Russia Injectable Drug Delivery Market, by value, 2016-2025 ($million)
128    South Africa Injectable Drug Delivery Market, by value, 2016-2025 ($million)
129    South Africa Injectable  Drug Delivery Market, by Devices 2016-2025 ($million)
130    RoW Injectable Drug Delivery Market, by value, 2016-2025 ($million)
131    RoW Injectable Drug Delivery Market, by Devices 2016-2025 ($million)
132    ALKERMES PUBLIC LIMITED COMPANY: Product Portfolio
133    ALKERMES PUBLIC LIMITED COMPANY: Overall Financials (2015-2017)
134    ALKERMES PUBLIC LIMITED COMPANY: Revenue by Region (2015-2017)
135    ALKERMES PUBLIC LIMITED COMPANY: SWOT Analysis
136    Antares Pharma: Overall Product Portfolio
137    Antares Pharma: Overall Financials (2015-2017)
138    Antares Pharma: Product Sales by Geographic Location (2015-2017)
139    Antares Pharma: SWOT Analysis
140    Baxter International Inc.: Product Portfolio
141    Baxter International Inc.: Overall Financials (2015-2017)
142    Baxter International Inc.: Revenue by Global Business Units(2015-2017)
143    Baxter International Inc.: Revenue by Geographical Location (2015-2017)
144    Baxter International Inc.: SWOT Analysis
145    Becton Dickinson and Company : Overall Product Portfolio
146    Becton, Dickinson and Company : Overall Financials (2015-2017)
147    Becton, Dickinson and Company: Product Sales by Region (2015-2017)
148    Becton, Dickinson and Company: Revenue by Business Segment (2015-2017)
149    Becton, Dickinson and Company: Revenue by Sub-Segment (2015-2017)
150    Becton Dickinson and Company: SWOT Analysis
151    Elcam Medical: Product Portfolio
152    Elcam Medical: SWOT Analysis
153    Eli-Lilly and Company: Overall Product Portfolio
154    Eli-Lilly and Company: Overall Financials (2014-2017)
155    Eli-Lilly and Company : Revenue by Business Segment (2014-2017)
156    Eli-Lilly and Company: Revenue by Geography (2014-2017)
157    Eli-Lilly and Company: SWOT Analysis
158    Gerresheimer  AG: Overall Product Portfolio
159    Gerresheimer  AG: Overall Financials (2015-2017)
160    Gerresheimer  AG: Revenue by Business Division (2015-2017)
161    Gerresheimer  AG: Revenue by Geographical Location (2015-2017)
162    Gerresheimer  AG: SWOT Analysis
163    Injex Pharma GmbH: Product Portfolio
164    Injex Pharma GmbH: SWOT Analysis
165    Novartis AG.: Overall Product Portfolio
166    Novartis AG : Overall Financials (2014-2017)
167    Novartis AG : Revenue by Region (2014-2017)
168    Novartis AG: Revenue by Business Segment (2014-2015)
169    Novartis AG: Revenue by Business Segment (2016-2017)
170    Novartis AG: SWOT Analysis
171    NOVO NORDISK: Overall Product Portfolio
172    NOVO NORDISK: Overall Financials (2015-2017)
173    NOVO NORDISK: Revenue by Business Segment (2015-2017)
174    NOVO NORDISK: Product Sales by Geographical Areas (2015-2017)
175    NOVO NORDISK: SWOT Analysis
176    Pfizer, Inc.: Product Portfolio
177    Pfizer Injectables: Product Portfolio
178    Pfizer Inc. : Overall Financials (2015-2017)
179    Pfizer Inc. : Revenue by Business Segment (2015-2017)
180    Pfizer, Inc. : Revenue by Geography (2015-2017)
181    Pfizer, Inc. : SWOT Analysis
182    PharmaJet: Product Portfolio
183    PharmaJet: SWOT Analysis
184    SANOFI: Overall Product Portfolio
185    SANOFI: Overall Financials (2015-2017)
186    SANOFI: Revenue by Business Segment (2015)
187    SANOFI: Revenue by Business Segment (2016-2017)
188    SANOFI: Revenue by Geography (2016-2017)
189    SANOFI: Revenue by Geography (2015)
190    SANOFI: SWOT Analysis
191    Schott AG: Overall Product Portfolio
192    Schott AG: Overall Financials (2015-2017)
193    Schott AG: Revenue by Geographical Location (2016-2017)
194    Schott AG: Revenue by Geographical Location(2015)
195    Schott AG: SWOT Analysis
196    Terumo Corporation: Overall Product Portfolio
197    Terumo Pharmaceutical Solutions: Product Portfolio
198    Terumo Corporation: Overall Financials (2015-2017)
199    Terumo Corporation: Revenue by Business Segment (2015-2017)
200    Terumo Corporation: Net Revenue by Region (2015-2017)
201    Terumo Corporation: SWOT Analysis
202    Teva Pharmaceuticals Industries Limited: Product Portfolio
203    Teva Pharmaceuticals Industries Limited.: Overall Financials (2015-2017)
204    Teva Pharmaceuticals Industries Limited.: Revenue by Business Segments (2015-2017)
205    Teva Pharmaceuticals Industries Limited.: Revenue by Geographical Location (2015-2017)
206    Teva Pharmaceuticals Industries Limited.: SWOT Analysis
207    Vetter Pharma-Fertigung GmbH & Co. KG: Product Portfolio
208    Vetter Pharma-Fertigung GmbH & Co. KG: SWOT Analysis
209    West Pharmaceutical Services, Inc.: Overall Product Portfolio
210    West Pharmaceutical Services, Inc.: Overall Financials (2015-2017)
211    West Pharmaceutical Services, Inc.: Revenue by Business Segment (2015-2017)
212    West Pharmaceutical Services, Inc.: Revenue by Geographical Location (2015-2017)
213    West Pharmaceutical Services, Inc.: SWOT Analysis
214    Ypsomed Holding AG: Product Portfolio
215    Ypsomed Holding AG: Overall Financials (2015-2017)
216    Ypsomed Holding AG: Revenue by Business Segments (2015-2017)
217    Ypsomed Holding AG: Revenue by Geographical Location (2015-2017)
218    Ypsomed Holding AG: SWOT Analysis
219    Global Injectable Drug Delivery Market Segmentation

Global Injectable Drug Delivery Market

Focus on Devices, Competitive Landscape and Country - Analysis and Forecast (2018-2025)